Public procurement notice: Contract Award Notice
Published: 2024-10-29
Buyer: Finnish Institute for Health and Welfare
Country: FI
Region: FI1B1
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value:  EUR
Award criteria: price, quality
EU fund: eu-funds

Technical requirements: Tenders must be submitted electronically via the Cloudia Supplier Portal. It is the responsibility of the tenderer to submit the tender by the deadline. No compensation will be paid for submitting a tender.

Requirements concerning tenderers and the Article, as well as eventual reports and explanations required in the tender, are described in this Call for tenders.

All the attachments mentioned in the Call for tenders should be sent with the tender. The tender must be submitted in writing, in English. Also, the annexes and all related material or correspondence must be in English.

The process steps are:

1. Opening the tenders.
2. Inspecting the suitability of tenderers according to the ESPD form.
3. Inspecting that tenders meet the requirements set in the Call for tenders.
4. Comparison of tenders.
5. Making and announcing the contract award decision.
6. Verifying the information given by the awarded tenderer on the ESPD form.
7. Background check by asking the winning tenderer to submit criminal record excerpts.
8. Drafting the Contract. The Contract is only valid after a written agreement is signed.

The Contract can be signed no earlier than 14 days from the time the tenderer has been informed, or is considered to have been informed, of the contract award decision and its grounds (=stand-still period).
Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for Various pharmaceutical products to the rescEU project. The Scope of procurement is described in more detail in Annex 1 to the Call for tenders.

The procurement is divided in fifteen (15) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots.

- LOT 1: Morphine 10-20 mg/ml (1-5 ml per vial/ampoule, i.m., ATC N02AA01)
- LOT 2: Ondansetron 2 mg/ml (2-4 ml per vial/ampoule, i.m. and i.v., ATC A04AA01)
- LOT 3: Ondansetron 4-8 mg per tablet/capsule, oral (ATC A04AA01)
- LOT 4: Hydrocortisone 250 mg / 2 ml (2 ml per vial/ampoule i.v., ATC H02AB09)
- LOT 5: Epinephrine (Adrenaline) 1 mg/ml (1-5 ml per vial/ampoule, i.v. and i.m., ATC C01CA24) 
- LOT 6: Diazepam 10 mg / 2 ml (2 ml per vial/ampoule, i.m. and i.v., ATC N05BA01)
- LOT 7: Midazolam 1-5 mg/ml (3-10 ml per vial/ampoule, i.v., ATC N05CD08)
- LOT 8: Salbutamol 200 µg/dose (inhaler, 60 or 200 doses, ATC R03AC02)
- LOT 9: Budesonide 0,5 mg/ml (2 ml nebuliser suspension per respule, ATC R03BA02)
- LOT 10: Ciprofloxacin 2 mg/ml (100-200 ml per vial/ampoule, i.v., ATC J01MA02)
- LOT 11: Streptomycin 1 g per vial/ampoule, i.m. (ATC J01GA01)
- LOT 12: Meropenem 500-1000 mg per vial/ampoule, i.v. (ATC J01DH02)
- LOT 13: Clindamycin 600 mg / 4 ml (4 ml per vial/ampoule, i.m. and i.v., ATC J01FF01)
- LOT 14: Ciprofloxacin 250-500 mg per tablet/capsule, oral (ATC J01MA02)
- LOT 15: Ethanol 95-96 % (5-20 ml per vial/ampoule, i.v., ATC V03AB16)

The minimum requirements for the products is described in Annex 1.1 to the Call for tenders.

The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

The contract period shall enter into force once the contract has been signed by Contracting parties and expires when all contractual duties of the Contract have been performed.

Estimated quantity for the products is described in Annex 6 (restricted to security classification level IV, TL IV) to the Call for tenders. In addition to the estimated quantity indicated in the Annex 6, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option.

Please note that all times given in the Call for tenders refer to local time in Finland.

Call for tenders, Annexes:
Annex 1 Scope of the procurement
Annex 1.1 Minimum requirements
Annex 2 Contract
Annex 3 Security annex
Annex 4 JYSE 2014 SUPPLIES (updated version of April 2022)
Annex 5 Confidentiality commitment
Annex 6 Estimated quantity (restricted, TL IV)

Please note that the numbering of the annexes differs between the Contract and the Call for tenders.
Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical ingredient (API) total quantity described in the Annex 6 (Estimated quantity, TL IV). The price shall be entered in the price field above in this section (exclusive of VAT). This price is used as the reference price of the tender.
The offered Article has as long as possible registered shelf life. Shelf life of 3 years (36 months) or more receives 30 points. Shelf life less than 3 years (36 months) receives 0 point.
50 % of the total quantity should be delivered as soon as possible. The faster the tenderer can deliver 50 % of the total quantity, the more points it will receive according to the menus described in the Call for tenders. A maximum of 40 points can be achieved.


Winner: FrostPharma AB
Award value: 5334100
Number of bids: 4